SAINT PAUL, Minn., Feb. 17, 2012 /PRNewswire/ -- Angeion Corporation (NASDAQ: ANGN) today scheduled a conference call to discuss its financial results for the first quarter fiscal 2012, ended January 31, 2012. The call will be at 5:00 p.m. ET on Tuesday, February 28, 2012. The Company will report financial results for the first quarter fiscal 2012 at the close of the market on Tuesday, February 28, 2012.
Those wishing to participate can dial (877) 317-6789 or (412) 317-6789 to access the conference call, or listen via a live Internet webcast on the Company's website at www.angeion.com. A replay of the conference call will be available by dialing (877) 344-7529 or (412) 317-0088, confirmation code 10010101, through March 5, 2012. A webcast replay of the conference call will be accessible on the Company's website at www.angeion.com for 90 days.
About Angeion Corporation
Founded in 1986, Angeion Corporation acquired Medical Graphics Corporation in December 1999. Medical Graphics develops, manufactures and markets non-invasive cardiorespiratory diagnostic systems that are sold under the MedGraphics (www.medgraphics.com) and New Leaf (www.newleaffitness.com) brand names. These cardiorespiratory product lines provide solutions for disease detection, integrated care, and wellness across the entire spectrum of health – whether managing chronic illness, promoting fitness, or training for the Olympics. The Company's products are sold internationally through distributors and in the United States through a direct sales force that targets heart and lung specialists located in hospitals, university-based medical centers, medical clinics and physicians' offices, pharmaceutical companies, medical device manufacturers, clinical research organizations, health and fitness clubs, personal training studios, and other exercise facilities. For more information about Angeion, visit www.angeion.com.
Contact: Robert M. Wolf
Joe Dorame, Robert Blum, Joe Diaz
Lytham Partners, LLC
Chief Financial Officer
|SOURCE Angeion Corporation|
Copyright©2010 PR Newswire.
All rights reserved